← Back to headlines
Clarivate Reaffirms Cash Flow Outlook, Advances Potential Sale
Clarivate has reaffirmed its $400 million free cash flow outlook while progressing with the potential sale of its Life Science & Healthcare division.
29 Apr, 17:22 — 29 Apr, 17:22
Sources
Showing 1 of 1 sources
